These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37160848)

  • 41. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
    Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
    Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delayed ischemic neurologic deficit with vasospasm in aneurysmal subarachnoid hemorrhage after negative post-bleed day 7 angiography.
    Winslow N; Ehsan M; Klopfenstein J
    Clin Neurol Neurosurg; 2022 Sep; 220():107353. PubMed ID: 35835022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Revisiting the Timeline of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: Toward a Temporal Risk Profile.
    Schmidt TP; Weiss M; Hoellig A; Nikoubashman O; Schulze-Steinen H; Albanna W; Clusmann H; Schubert GA; Veldeman M
    Neurocrit Care; 2022 Dec; 37(3):735-743. PubMed ID: 35790670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-Dependent Radiographic Vasospasm and Delayed Cerebral Ischemia in Women After Aneurysmal Subarachnoid Hemorrhage.
    Lai PMR; Gormley WB; Patel N; Frerichs KU; Aziz-Sultan MA; Du R
    World Neurosurg; 2019 Oct; 130():e230-e235. PubMed ID: 31203057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of delayed cerebral ischemia after subarachnoid hemorrhage.
    Francoeur CL; Mayer SA
    Crit Care; 2016 Oct; 20(1):277. PubMed ID: 27737684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal Expression Pattern of Hemoxygenase-1 Expression and Its Association with Vasospasm and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
    Frase S; Steimer M; Selzner L; Kaiser S; Foit NA; Niesen WD; Schallner N
    Neurocrit Care; 2022 Feb; 36(1):279-291. PubMed ID: 34312792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution.
    Macdonald RL; Pluta RM; Zhang JH
    Nat Clin Pract Neurol; 2007 May; 3(5):256-63. PubMed ID: 17479073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms.
    Reynolds MR; Buckley RT; Indrakanti SS; Turkmani AH; Oh G; Crobeddu E; Fargen KM; El Ahmadieh TY; Naidech AM; Amin-Hanjani S; Lanzino G; Hoh BL; Bendok BR; Zipfel GJ
    J Neurosurg; 2015 Oct; 123(4):862-71. PubMed ID: 26207606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early Vasospasm after Aneurysmal Subarachnoid Hemorrhage Predicts the Occurrence and Severity of Symptomatic Vasospasm and Delayed Cerebral Ischemia.
    Jabbarli R; Reinhard M; Shah M; Roelz R; Niesen WD; Kaier K; Taschner C; Weyerbrock A; Van Velthoven V
    Cerebrovasc Dis; 2016; 41(5-6):265-72. PubMed ID: 26836215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral hemodynamic impairment after aneurysmal subarachnoid hemorrhage as evaluated using transcranial doppler ultrasonography: relationship to delayed cerebral ischemia and clinical outcome.
    Rätsep T; Asser T
    J Neurosurg; 2001 Sep; 95(3):393-401. PubMed ID: 11565859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thick and diffuse cisternal clot independently predicts vasospasm-related morbidity and poor outcome after aneurysmal subarachnoid hemorrhage.
    Aldrich EF; Higashida R; Hmissi A; Le EJ; Macdonald RL; Marr A; Mayer SA; Roux S; Bruder N
    J Neurosurg; 2021 May; 134(5):1553-1561. PubMed ID: 32442971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled transient hypercapnia: a novel approach for the treatment of delayed cerebral ischemia after subarachnoid hemorrhage?
    Westermaier T; Stetter C; Kunze E; Willner N; Holzmeier J; Kilgenstein C; Lee JY; Ernestus RI; Roewer N; Muellenbach RM
    J Neurosurg; 2014 Nov; 121(5):1056-62. PubMed ID: 25148012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [General management in intensive care of patient with spontaneous subarachnoid hemorrhage].
    Guerrero López F; de la Linde Valverde CM; Pino Sánchez FI
    Med Intensiva; 2008 Oct; 32(7):342-53. PubMed ID: 18842226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral Vasospasm and Delayed Cerebral Ischemia after Warfarin-Induced Subarachnoid Hemorrhage.
    Ricarte IF; Calente FG; Alves MM; Gomes DL; Valiente RA; Carvalho FA; Silva GS
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):e275-8. PubMed ID: 26198372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage.
    Juvela S
    J Neurosurg; 2000 Mar; 92(3):390-400. PubMed ID: 10701524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subarachnoid Hemorrhage.
    Chou SH
    Continuum (Minneap Minn); 2021 Oct; 27(5):1201-1245. PubMed ID: 34618758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicenter prospective cohort study on volume management after subarachnoid hemorrhage: hemodynamic changes according to severity of subarachnoid hemorrhage and cerebral vasospasm.
    Yoneda H; Nakamura T; Shirao S; Tanaka N; Ishihara H; Suehiro E; Koizumi H; Isotani E; Suzuki M;
    Stroke; 2013 Aug; 44(8):2155-61. PubMed ID: 23735953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage.
    Sen J; Belli A; Albon H; Morgan L; Petzold A; Kitchen N
    Lancet Neurol; 2003 Oct; 2(10):614-21. PubMed ID: 14505583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage.
    Origitano TC; Wascher TM; Reichman OH; Anderson DE
    Neurosurgery; 1990 Nov; 27(5):729-39; discussion 739-40. PubMed ID: 2259403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.